Types | Virus | Effects of AHR signaling pathways after virus infections | Corresponding influence | Reference |
---|---|---|---|---|
RNA | ZIKV | Promote the synthesis of AHR endogenous ligand Kyn by upregulating IDO1 and TDO2, thereby activating the AHR signaling pathway | Inhibit IFN-I expression and reduce the body's antiviral ability; at the same time, after activation of AHR, it can inhibit the NF-κB signaling pathway to limit the intrinsic immunity driven by PML protein, which is conducive to the replication of ZIKV in vivo | [24] |
SARS-CoV-2 | Promote the synthesis of AHR endogenous ligand Kyn via promoting the expression of IFN-β、γ to upregulate IDO1, thereby activating the AHR signaling pathway | Stimulate mucins production, thereby promoting hypoxia by hindering O2 diffusion at alveolar sites; on the other hand, AHR activation, in turn, promotes virus replication | [57] [59] | |
HCV | Activate the AHR signaling pathway by upregulating the AHR endogenous ligand Kyn | After activation of AHR, the expression of its downstream target gene CYP1A1 increases, promoting the formation of LDs and accumulation of liver fat, which is closely related to the progression of HCC | [62] | |
IAV | Possibly activate the AHR signaling pathway by upregulating Kyn levels | Diminish host responses and reduce cytotoxic T lymphocytes production, thereby reducing cellular antiviral immunity | [102] | |
HTLV-1 | AHR is activated, but the exact mechanism is unknown | Facilitate HTLV-1 plus-strand transcription and control viral latency-reactivation switching | [104] | |
HIV-1 | In the lymphocyte, AHR activation promotes HIV-1 infection and reactivation; in the macrophage, AHR activation causes a block to HIV-1 replication | In the lymphocyte, AHR directly binds to the HIV-1 5′-LTR; in the macrophage, AHR activation surpresses the transcription of CDK1, CDK2, resulting in dNTP depletion and antiviral effects | ||
DNA | EBV | EBV-encoded EBNA3 facilitates the role of the AHR pathway by promoting AHR nuclear translocation in B lymphocytes; EBV-encoded LMP1 affects AHR signaling pathway by activating NF-κB in B lymphocytes; EBV-encoded LMP2A suppresses the role of the AHR pathway through the ERK signal pathway in EBV-associated gastric cancer | In B lymphocytes, EBNA3 activates AHR, which in turn promotes EBV to enter the lytic phase, and it is conducive to virus replication; In gastric cancer cells, inhibition of AHR by LMP2A favors EBV to maintain a latent state | [72] [78] [93] |
HCMV | Increase Kyn levels by promoting Kyn synthesis and inhibiting Kyn metabolism in fibroblasts, thereby activating the AHR signaling pathway | AHR activation following HCMV infection, in turn, promotes efficient production of viral progeny; And it promotes HCMV-Induced G1/S block to cell cycle progression, thereby preventing cell proliferation and preserving metabolic resources for viral progeny | [100] |